🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

$BDA CEO Jo Patterson caught up with Eureka Report is now part of Intelligent Investor's Alan Kohler to discuss the use of #cannabis in the #medical, #healthcare & #recreational sectors & the growing acceptance of its use in Australia, to treat stress, anxiety and pain. READ HERE: eurekareport.com.au/investment-new…

For those new to the #AccessInvesting story, here is a quick overview of how we provide private #company #investments to the public & how we disrupt the market for private #company investing. To view the prospectus & apply, visit accessinvesting.com.au/prospectus #ASX #Investing #IPO ⬇

Ecs Botanics Holdings Ltd $ECS $ECS.AX New #ASX investor presentation: Investor Presentation See the full deck at freshequities.com/ASX/ECS/?deck=1

.Pitt Street Research has published a new report on ECS Botanics, "Running hard in the lucrative medicinal cannabis space". With valuation range of $0.12-0.16 per share. You can view the full report here: pittstreetresearch.com/ecs-botanics #medicinalcannabis #cannabis #potstocks $ECS #ASX

Here’s one the ASX won’t be too happy about. bit.ly/2Z859hB

$BOD was featured in The Australian after it secured Clinical Trial Authorisation to commence a UK-based trial into medicinal cannabis efficacy on long #COVID READ ➡ bit.ly/3qA5MvF $BOD.ax #cannabis #ASX

From Stockhead: "Nanollose Ltd (#ASX: #NC6) has partnered with one of the world’s largest #fibre manufacturers, as leading fashion brands eagerly await results of the pilot spin of its tree-free #lyocell fibre, later this month." Read more⬇️ stockhead.com.au/health/why-nan…

$ECS Botanics is pleased to provide recent Investor Presentation, including the Company's strategic initiatives with focus on #medicinalcannabis production at Victorian operations. To view: bit.ly/3aimMkV $ECS.ax #potstocks #ASX

Hydralyte FY22 Quarterly Report: ⬆ Revenue achieved with US$2.2m in net sales, representing 56% growth on PCP ⬆ 18% increase on the last quarter ⬆ Revenue underpinned by monthly net sales of US$0.95m in June Read more: bit.ly/3Sc8IL1 $HPC.ax $HPC #hydration #ASX

Great summary of ASX #Cannabis stocks on Stockhead. Good to see ECS kicking some goals with its latest quarterly! $LGP -$3.62M operating net cash vs. #CAN -$7.1M. $ECS Market Cap $29M and -$0.78M stockhead.com.au/health/weed-we… @PeakAsset

New products, strong online and retail sales drive record quarterly revenue for The Hydration Pharmaceuticals Company (#ASX: $HPC) smallcaps.com.au/new-products-o… HydralyteASX:HPC

Mount Burgess Mining (#ASX: $MTB) Chairman and Managing Director Nigel Forrester is presenting a #webinar tomorrow with 180 Markets at 1pm AEST. To join: bit.ly/3QhMkxt #mining #exploration #ASX

All eyes were on $LIN following its agreement to acquire 100% of #Kangankunde #RareEarths Project. Far East Capital's Warwick Grigor discusses what separates this project from other #rareearths projects in the world. FULL VIDEO: youtu.be/zHpeMxilUrI $LIN.ax #ASX

Here are the 10 best performing ASX battery metals stocks over the past year 👇🏾 $LIN Lindian Resources Limited stockhead.com.au/resources/high… $LIN

Hydralyte Q3 FY22 Quarterly Report ⬆ US$2.44m in net sales - 17% increase PCP ⬆ Growth underpinned by 56% rise in sales to major Canadian retail groups ⬆ 9 new products launched during quarter Read more: bit.ly/3sPz2ih $HPC $HPC.ax #ASX

10 pitch decks that raised $15 Billion:

The Kangankunde Rare Earths Project - A Tier 1 mine in the making

Rare Earths drilling highlights — Q1

📢 TrivarX Limited (#ASX: $TRI) will host an investor webinar on Friday, May 24, 2024, at 11:00 AM AEST (9:00 AM AWST). COO Kai Sun will update on the Phase 2 SAMDE study and the pathway to US FDA approval for the MEB-001 algorithm. Register now: register.gotowebinar.com/register/24510… #AI